JINJIANG XUANHONG EQUITY INVESTMENT
JINJIANG XUANHONG EQUITY INVESTMENT
Status:
Active
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-12-31 | XuanZhu Pharma | Jinjiang Xuanhong Equity Investment investment in Series B - XuanZhu Pharma | 610.5 M CNY |
More informations about "Jinjiang Xuanhong Equity Investment"
Jinjiang Xuanhong Equity Investment - Crunchbase
Dec 31, 2021 Jinjiang Xuanhong Equity Investment has invested in XuanZhu Pharma on Dec 31, 2021. This investment - Series B - XuanZhu Pharma - was valued at . obfuscated. …See details»
Jinjiang Xuanhong No.1 Equity Shares Investment Partnership …
Find company research, competitor information, contact details & financial data for Jinjiang Xuanhong No.1 Equity Shares Investment Partnership Enterprise (Limited Partnership) of …See details»
| Sihuan Pharmaceutical Holdings Group
Xuanzhu Biopharmaceutical Co., Ltd.( “Xuanzhu Biopharm”) has completed a Series B financing of RMB610.5 million on December 31, 2021. This round of financing was led by Sunshine Life …See details»
Jinjiang Xuanhong Equity Investment - Web3 Crypto Company …
Jinjiang Xuanhong Equity Investment is an investment company. News; Insight; Currencies; Columns; Events; Search. Recently Searched Hot Coins Trending Daily Must-Read English. …See details»
Jinjiang Xuanhong Equity Investment - app.dealroom.co
Jinjiang Xuanhong Equity Investment Private equity Claimed. Overview. Portfolio (0) Notes. Recent News about Jinjiang Xuanhong Equity Investment Edit.See details»
Sihuan Pharmaceutical (0460.HK): Sunshine Life Insurance Leads ...
May 28, 2024 This round of financing was led by Sunshine Life Insurance Corporation Limited and joined by Efung Capital, Zhongji Investment Co., Ltd., TJ Capital, SDIC Taikang Trust Co., …See details»
Jinjiang Xuanhong Equity Investment - Unicorn Nest
Jinjiang Xuanhong Equity Investment. Search. Overview Investments Unlock datapoints. Portfolio analytics Team News & Media. Add fund to favorites. Save this fund for later to form your own …See details»
Jinjiang Xuanhong Equity Investment - Crunchbase
Jinjiang Xuanhong Equity Investment is an investment company.See details»
XuanZhu Pharma - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Dec 31, 2021: Series B - …See details»
Sunshine Insurance Leads ~USD96m Series B for China’s Xuanzhu …
Sunshine Insurance led a CNY600m (~USD96m) Series B for China-based biopharma Xuanzhu Biopharm, with participation from Efung Capital, Zhongji Investment, TJ Capital, SDIC …See details»
12 investors including Sunshine Life Insurance Co., Ltd ... - moomoo
SihuanPharmaceutical (00460.HK) announced that 12 investors, including Sunshine Life Insurance, Jinjiang Xuanhong No. 3 Equity Investment Partnership and Bank of China Capital …See details»
Beijing Luzhu Biotechnology Co., Ltd. - finchat.io
Jian Kong is the largest shareholder of Beijing Luzhu Biotechnology Co., Ltd. with 0% of the shares. View the entire shareholder list and ownership changes for Beijing Luzhu …See details»
Sihuan Pharmaceutical (0460.HK): Sunshine Life Insurance
Jan 3, 2022 The new investment we gained will help Xuanzhu Biopharm to accelerate its vision of an innovative biopharmaceutical company rooted in China with a global perspective." About …See details»
Jinjiang Xuanhong Equity Investment - Updates, News
Jinjiang Xuanhong Equity Investment is an investment company.See details»
Who Owns Fairmont Hotels and Resorts? | Business Strategy Hub
Dec 11, 2024 Other top players are Pzena Investment at 5.98%, Shanghai State-owned Assets at 5.39%, Harris Associates at 5.17%, Barings Ltd at 2%, and Amundi Asset at 1.56%. In Mar …See details»
Relief or "bottom fishing"? Four insurance companies have …
NCI has taken over Wanda assets within the year, adding Wanda Plaza in Chifeng and Jinjiang, with an increasing investment in held real estate project assets. Tianjin Kunhua, as the wholly …See details»
Series B - XuanZhu Pharma - 2021-12-31 - Crunchbase
Jan 3, 2022 XuanZhu Pharma raised $96052486 on 2021-12-31 in Series B. Start Free Trial . Chrome ExtensionSee details»
Nanjing Fuze - Crunchbase
Nanjing Fuze is an investment company. Similar Companies. Edit Similar Companies SectionSee details»